Subscribe to RSS
DOI: 10.1055/s-0034-1368218
Long-Term Efficacy of Selective Laser Trabeculoplasty in Patients on Prostaglandin Therapy
Langzeitwirksamkeit der selektiven Lasertrabekuloplastik bei Patienten unter ProstaglandintherapiePublication History
received 08 September 2013
accepted 01 January 2014
Publication Date:
25 April 2014 (online)
![](https://www.thieme-connect.de/media/klimo/201404/lookinside/thumbnails/10.1055-s-0034-1368218-1.jpg)
Abstract
Background: The aim of the study was to analyse the efficacy of selective laser trabeculoplasty in patients on medical therapy and to evaluate a possible influence of prostaglandin therapy on intraocular pressure reduction. Patients and Methods: A retrospective chart review was undertaken of patients with ocular hypertension or open angle glaucoma who underwent selective laser trabeculoplasty between 3/2008 and 12/2010. Data were collected preoperatively, on the day of intervention, 1 day, 1 month and then every 3 months post selective laser trabeculoplasty. The main outcome measure was mean intraocular pressure reduction. Results: 109 eyes (76 on prostaglandins) were included. Mean preoperative intraocular pressure was 22.3 ± 4.5 mmHg (prostaglandin naïve) and 19.2 ± 4.8 mmHg (on prostaglandin) (p = 0.003). Up to 1 year follow-up, intraocular pressure was statistically significantly reduced in both groups (p ≤ 0.019). Eyes with a higher preoperative intraocular pressure had a greater pressure reduction (Spearman rho = 0.387, p = 0.002). Eyes naïve to prostaglandins initially had a greater reduction in intraocular pressure, although after 1 year of follow-up the difference was no longer statistically significant. Conclusions: Selective laser trabeculoplasty significantly reduces intraocular pressure in patients already on medical therapy. A sustained influence of prostaglandin therapy on the efficacy of selective laser trabeculoplasty was not found.
Zusammenfassung
Hintergrund: Ziel der Studie war, die augendrucksenkende Wirkung der selektiven Lasertrabekuloplastik bei Patienten unter Therapie sowie einen möglichen Einfluss von Prostaglandin-Therapie auf die Drucksenkung zu untersuchen. Patienten und Methoden: Retrospektive Kohortenstudie von Patienten mit okulärer Hypertension oder Offenwinkelglaukom, die von 3/2008 bis 12/2010 eine selektive Lasertrabekuloplastik hatten. Augendruckwerte vor, am Tag der selektiven Lasertrabekuloplastik, einen Monat und dann 3-monatlich nach Laserbehandlung wurden ausgewertet. Hauptergebnis war die mittlere Augendrucksenkung. Ergebnisse: 109 Augen (76 mit Prostaglandin-Therapie) wurden inkludiert. Der mittlere präoperative Augendruck war 22.3 ± 4.5 mmHg (ohne Prostaglandine) und 19.2 ± 4.8 mmHg (mit Prostaglandinen) (p = 0,003). Bis zu einem Jahr war der Augendruck in beiden Gruppen signifikant reduziert (p ≤ 0,019). Augen mit höherem präoperativen Augendruck hatten eine stärkere Drucksenkung (Spearman rho = 0,387, p = 0,002). Augen ohne Prostaglandin-Therapie hatten initial eine stärkere Drucksenkung als Augen mit Prostaglandin-Therapie; der Unterschied war nach einem Jahr nicht mehr signifikant. Schlussfolgerungen: Selektive Lasertrabekuloplastik reduziert bei Patienten unter Therapie den Augendruck signifikant. Ein dauerhafter Effekt von Prostaglandin-Therapie auf die Drucksenkung wurde nicht gefunden.
-
References
- 1 Damji KF, Bovell AM, Hodge WG et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. Br J Ophthalmol 2006; 90: 1490-1494
- 2 Alvarado JA, Iguchi R, Martinez J et al. Similar effects of selective laser trabeculoplasty and prostaglandin analogs on the permeability of cultured Schlemm canal cells. Am J Ophthalmol 2010; 150: 254-264
- 3 Martow E, Hutnik CM, Mao A. SLT and adjunctive medical therapy: a prediction rule analysis. J Glaucoma 2011; 20: 266-270
- 4 Song J, Lee PP, Epstein DL et al. High failure rate associated with 180 degrees selective laser trabeculoplasty. J Glaucoma 2005; 14: 400-408
- 5 Shazly TA, Latina MA, Dagianis JJ et al. Effect of prior cataract surgery on the long-term outcome of selective laser trabeculoplasty. Clin Ophthalmol 2011; 5: 377-380
- 6 Almeida EDJ, Pinto LM, Fernandes RA et al. Pattern of intraocular pressure reduction following laser trabeculoplasty in open-angle glaucoma patients: comparison between selective and nonselective treatment. Clin Ophthalmol 2011; 5: 933-936
- 7 McIlraith I, Strasfeld M, Colev G et al. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma 2006; 15: 124-130
- 8 Toris CB, Gabelt BT, Kaufman PL. Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Ophthalmol 2008; 53 (Suppl. 01) S107-S120
- 9 Goyal S, Beltran-Agullo L, Rashid S et al. Effect of primary selective laser trabeculoplasty on tonographic outflow facility: a randomised clinical trial. Br J Ophthalmol 2010; 94: 1443-1447
- 10 Gracner T, Pahor D, Gracner B. [Efficacy of selective laser trabeculoplasty in the treatment of primary open-angle glaucoma]. Klin Monatsbl Augenheilkd 2003; 220: 848-852
- 11 Mao AJ, Pan XJ, McIlraith I et al. Development of a prediction rule to estimate the probability of acceptable intraocular pressure reduction after selective laser trabeculoplasty in open-angle glaucoma and ocular hypertension. J Glaucoma 2008; 17: 449-454